A major milestone on the classification of the breast carcinomas is the so called “intrinsic classification”, which divides breast tumors into at least five clinically and biologically relevant intrinsic molecular subtypes based on genome-wide expression analyses: luminal A, luminal B, HER2-enriched, basal-like, and normal breast-like. Here, ERBB2 is linked to breast carcinoma.